DCTH

Delcath Systems' stock price has seen significant movement, increasing by 61.96% over the last 12 months and 66.93% year-to-date. In the past month, the stock increased by 31.62%. On August 6, 2026, the company reported Q2 2026 earnings per share (EPS) of $0.07, exceeding analysts' expectations of -$0.10 by 170.00%. Following this announcement, DCTH shares gained +22.5% the next day, closing at $15.47, and have since drifted +10.8% higher. The company also raised its full-year 2026 revenue guidance to $104 million to $108 million, reflecting at least 28% growth in HEPZATO KIT volume over 2025. The next earnings announcement is estimated between October 20, 2026, and October 30, 2026. The company also announced inducement grants of equity awards to new employees in July and August 2026 and presented at the H.C. Wainwright 28th Annual Global Investment Conference.